Feasibility of Therapeutic Effects of the Cholinergic Anti-Inflammatory Pathway on COVID-19 Symptoms
- PMID: 32378064
- PMCID: PMC7202901
- DOI: 10.1007/s11481-020-09919-6
Feasibility of Therapeutic Effects of the Cholinergic Anti-Inflammatory Pathway on COVID-19 Symptoms
Conflict of interest statement
The author declare that there is no conflict of interest.
Comment on
-
COVID-19: consider cytokine storm syndromes and immunosuppression.Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16. Lancet. 2020. PMID: 32192578 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
